Randomized Study Comparing CMF and Goserelin + Tamoxifen in Premenopausal Receptor-positive Patients
Status:
Completed
Trial end date:
2004-06-01
Target enrollment:
Participant gender:
Summary
Primarily, this clinical investigation compared the efficacy of cyclophosphamide +
methotrexate + fluorouracil chemotherapy vs. goserelin + tamoxifen treatment in terms of
prognosis (disease-free survival, overall survival) in premenopausal patients with
potentially curative, operated hormone receptor-positive breast cancer.